$FWDG - CEO Letter to our shareholders 02/19/2015
Dear Shareholders;
We have heard many concerns on our declining share price for the past few weeks from our shareholders and I wanted to drop you a line and give you some information that may be helpful for you to navigate through this concern.
Per our SEC submissions and filings a few months ago, the Company raised much needed funding from a few investors through convertible debt instruments so we could start to execute our business plan. Funding at that initial stage, and especially in our restricted industry, always comes at a premium. As you may know, banks and major financial institutions will not consider funding businesses in the Cannabis market. That can and often does include hedge funds, major broker/dealer firms and angel/ VC funds. Even funding at the SEC registration level (S1 & such) is not available for our industry (Though that is about to change). These limitations could change in 2016 with national availability of banking services to cannabis companies and federal government’s access to IPOs for cannabis related publicly traded companies, but it is not well definite at this time.
The convertible debt instruments started becoming due mid-November and the funders have been converting their debts into free trading shares, based on the funding agreements. The funders are at the latter stage of their conversions and our stock should recoup and reclaim its previous share price position and move onward from there. This process is fairly similar to a “Lock-Up Expiration” that happens to all new publicly traded companies. In no way, the share price decline during this process, is a signifier of the health of the Company. It is purely a supply vs. demand response of the market.
Neither the Company nor its insiders/management have sold any shares or are planning to do so in the near future.
The funding allowed FutureWorld to hasten its execution of its business plan to incubate and fund five (5) subsidiaries with award winning products, thousands of customers and close $1.2m in revenue in only 9 months while growing exponentially at around 500% per quarter. Our net assets will increase substantially in the next few weeks and months by our planned exit strategies (sale) for our subsidiaries, including HempTech Corp., URVape, CB Scientific and FutureLand properties.
Although the funding came at a heavy cost, it is directly responsible for taking our company from zero to $1.2m in only nine months. For now, our plan is to continue our business model of incubating and funding more companies in the cannabis industry and adding value to our investors and shareholders. With the Cannabis industry expanding and becoming one of the largest industries in the world in such a short period of time, FutureWorld is properly positioned to capitalize upon its competitive advantage and offer great returns to its shareholders.
Regards
Sam Talari
Chairman & CEO
FutureWorld Corp
HQ: 3637 Fourth Street North, Suite 330
St. Petersburg, Florida 33704
O: (727) 474-1816 ext. 101
http://www.futureworldcorp.com
Dear Shareholders;
We have heard many concerns on our declining share price for the past few weeks from our shareholders and I wanted to drop you a line and give you some information that may be helpful for you to navigate through this concern.
Per our SEC submissions and filings a few months ago, the Company raised much needed funding from a few investors through convertible debt instruments so we could start to execute our business plan. Funding at that initial stage, and especially in our restricted industry, always comes at a premium. As you may know, banks and major financial institutions will not consider funding businesses in the Cannabis market. That can and often does include hedge funds, major broker/dealer firms and angel/ VC funds. Even funding at the SEC registration level (S1 & such) is not available for our industry (Though that is about to change). These limitations could change in 2016 with national availability of banking services to cannabis companies and federal government’s access to IPOs for cannabis related publicly traded companies, but it is not well definite at this time.
The convertible debt instruments started becoming due mid-November and the funders have been converting their debts into free trading shares, based on the funding agreements. The funders are at the latter stage of their conversions and our stock should recoup and reclaim its previous share price position and move onward from there. This process is fairly similar to a “Lock-Up Expiration” that happens to all new publicly traded companies. In no way, the share price decline during this process, is a signifier of the health of the Company. It is purely a supply vs. demand response of the market.
Neither the Company nor its insiders/management have sold any shares or are planning to do so in the near future.
The funding allowed FutureWorld to hasten its execution of its business plan to incubate and fund five (5) subsidiaries with award winning products, thousands of customers and close $1.2m in revenue in only 9 months while growing exponentially at around 500% per quarter. Our net assets will increase substantially in the next few weeks and months by our planned exit strategies (sale) for our subsidiaries, including HempTech Corp., URVape, CB Scientific and FutureLand properties.
Although the funding came at a heavy cost, it is directly responsible for taking our company from zero to $1.2m in only nine months. For now, our plan is to continue our business model of incubating and funding more companies in the cannabis industry and adding value to our investors and shareholders. With the Cannabis industry expanding and becoming one of the largest industries in the world in such a short period of time, FutureWorld is properly positioned to capitalize upon its competitive advantage and offer great returns to its shareholders.
Regards
Sam Talari
Chairman & CEO
FutureWorld Corp
HQ: 3637 Fourth Street North, Suite 330
St. Petersburg, Florida 33704
O: (727) 474-1816 ext. 101
http://www.futureworldcorp.com
